Protein production and purification
The human wt-ERα LBD and the ERα-Y537S LBD mutant (amino acids 302-552) were cloned into a modified pET-15b vector resulting in a fusion protein containing a thioredoxinehexahistidine tag at the N-terminus, and purified as described in (Delfosse et al. 2012 ). The human wt-ERβ LBD (amino acids 261-502) was cloned into a pET-32a vector. Gene expression was induced in BL21(DE3) cells overnight at 18°C in LB medium without any ligand and the protein was purified in the apo form. The cell lysate was first applied onto a nickel affinity column (HiTrap 5 mL; GE Healthcare). The eluted protein was then applied onto a desalting column (HiPrep 26/10 Desalting; GE Healthcare) equilibrated with 20 mM Tris pH 8.0, 50 mM NaCl, 5 mM DTT and 5% glycerol and the N-terminal thioredoxine-hexahistidine tag was subsequently removed by adding TEV protease overnight at 4°C. The protein was separated from the cut tag by size exclusion chromatography (Superdex 75 HR 16/60; GE Healthcare) and then concentrated in the gel filtration buffer (20 mM Tris pH 8.0, 150 mM NaCl, 5 mM DTT and 10% glycerol). Proteins are stored at -40°C.
Data collection and structure determination
For all complexes, native data were collected from one crystal cryoprotected with 30% glycerol on the ID23-1, ID23-2 or ID29 beamlines at the European Synchrotron Radiation Facility, Grenoble, France. Data were processed and scaled with XDS and XSCALE (Kabsch 2010) .
Crystals belong to space group P2 1 for all complexes. The X-ray structures were solved by molecular replacement method using PHENIX (phenix.automr) (Adams et al. 2010 ), and refinement and rebuilding were performed with COOT (Emsley and Cowtan 2004) , PHENIX (phenix.refine) (Adams et al. 2010) and REFMAC (Murshudov et al. 1997 ) from the CCP4 (Winn et al. 2011) 3.34 ± 1.14 10 Figure S1 . Values are the mean ± SD from three separate experiments. 
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